Mingxing Lu, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Lange Aroucha Vickers Lisa J
Choosing the right one also comes down to fit: the type of work you are doing, the support you need, and the value you get
Seven different GLP-1 receptor agonists were used, including semaglutide (Ozempic or Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza)
found that GLP-1 RAs are associated with an increased risk of gallbladder and biliary diseases (including cholelithiasis and cholecystitis), particularly at higher doses, longer treatment durations, and when used for weight loss [129]
This compound is studied for its potential to support lipolysis, improve mitochondrial function, and enhance energy expenditure in experimental models